KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $134,387 | +391.3% | 13,955 | +359.2% | 0.00% | – |
| Q2 2023 | $27,351 | +351.0% | 3,039 | +238.8% | 0.00% | – |
| Q4 2022 | $6,064 | -87.1% | 897 | -66.6% | 0.00% | – |
| Q3 2021 | $47,000 | +4.4% | 2,689 | +42.0% | 0.00% | – |
| Q2 2021 | $45,000 | -44.4% | 1,894 | -40.2% | 0.00% | – |
| Q1 2021 | $81,000 | +1925.0% | 3,169 | +1423.6% | 0.00% | – |
| Q4 2020 | $4,000 | – | 208 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |